Literature DB >> 4866104

Cryptococcus neoformans. 3. Inhibition of phagocytosis.

G S Bulmer, M D Sans.   

Abstract

Isolated nonhydrolyzed cryptococcal polysaccharide is a rather specific potent inhibitor of the phagocytosis of Cryptococcus neoformans by human leukocytes in vitro. When an encapsulated strain of C. neoformans was cultured in the nonencapsulated state, the rate of phagocytosis was three times greater than when the encapsulated form was used. Our theory that capsular material plays a role in the pathogenesis of cryptococcosis requires (i) that C. neoformans exist in soil in a nonencapsulated state and (ii) that human phagocytes be capable of killing the organisms.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4866104      PMCID: PMC251963          DOI: 10.1128/jb.95.1.5-8.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  Effect of degree of encapsulation upon virulence of Cryptococcus neoformans.

Authors:  M L LITTMAN; E TSUBURA
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

2.  Passively-acquired immunity in experimental cryptococcosis.

Authors:  D B Louria; T Kaminski
Journal:  Sabouraudia       Date:  1965-06

3.  Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis.

Authors:  I Abrahams
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

4.  Investigations on the structure of the capsular polysaccharide from Cryptococcus neoformans type B.

Authors:  A Blandamer; I Danishefsky
Journal:  Biochim Biophys Acta       Date:  1966-04-25

5.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

6.  Cryptococcus neoformans. I. Nonencapsulated mutants.

Authors:  G S Bulmer; M D Sans; C M Gunn
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

  6 in total
  68 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Expression of capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Rui Kano; Shinichi Watanabe; Atsuhiko Hasegawa
Journal:  Mycopathologia       Date:  2005-08       Impact factor: 2.574

3.  Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.

Authors:  Marcellene A Gates; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 4.  Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.

Authors:  Neena Jain; Abraham Guerrero; Bettina C Fries
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

5.  Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.

Authors:  R Blackstock; J W Murphy
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 6.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

7.  Cryptococcal capsular polysaccharide clearance in nonimmune mice.

Authors:  H G Muchmore; E N Scott; F G Felton; R A Fromtling
Journal:  Mycopathologia       Date:  1982-04-23       Impact factor: 2.574

Review 8.  Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition.

Authors:  Stephanie C Ray; Chad A Rappleye
Journal:  Semin Cell Dev Biol       Date:  2018-03-21       Impact factor: 7.727

9.  Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay.

Authors:  T Belay; R Cherniak; T Shinoda
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.